AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2021
Aug 6, 2021
35475_dirs_2021-08-06_d468901c-cfc5-4fcb-b0e8-cf37baba334d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2021-08-03
Reporting Person: Lee Hoonmo (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 694522 | Indirect |
Footnotes
F1: Consists of 694,522 shares of common stock held by TY Bio Investment, Inc. Mr. Lee shares investment authority over TY Bio Investment, Inc. Accordingly, Mr. Lee may be deemed to beneficially own the shares of Indaptus Therapeutics, Inc. common stock held by TY Bio Investment.
More from Indaptus Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12
Director's Dealing
2026
Jan 23